News Lookbook Collaborate Salaries Per Diem Marketplace Tools Referrals

B-Seen

The eye care industry's career marketplace — free for job seekers and independent practices.

Professionals

Find a Job
Create Profile
Lookbook
Collaborate

Pay & Career

Salary Transparency
Methodology
Career Tools
Field of View News

Employers

Post a Job
Corporate Partners
Pricing
Equipment Marketplace

Connect

About Us
Contact

Privacy Terms Cookies Accessibility Privacy Requests

B-Seen is operated by B-SEEN, LLC, 300 Needham St, Suite 4, Newton, MA, USA.

B-Seen

The eye care industry's career marketplace — free for job seekers and independent practices because the cost of hiring shouldn't be a barrier for the small, doctor-owned offices that are the backbone of eye care.

Professionals

Find a Job
Create Profile
Lookbook
Collaborate

Pay & Career

Salary Transparency
Methodology
Career Tools
Field of View News

Employers

Post a Job
Corporate Partners
Pricing
Equipment Marketplace

Connect

About Us
Contact

Privacy Terms Cookies Accessibility Privacy Requests

B-Seen is operated by B-SEEN, LLC, 300 Needham St, Suite 4, Newton, MA, USA. Contact: legal@b-seen.io

FDA Rationale for Breakpoints Recognition Decision for Disk Diffusion: Azithromycin and Neisseria gonorrhoeae | Field of View | B-Seen

Article

Back to Feed

FDA Approvals

FDA Rationale for Breakpoints Recognition Decision for Disk Diffusion: Azithromycin and Neisseria gonorrhoeae

FDA2d ago1 min read

FDA has identified the disk diffusion inhibition zone diameters based on correlation with the FDA azithromycin minimum inhibitory concentration (MIC) breakpoints for Neisseria gonorrhoeae.

Read full article on FDA

Discussion

No comments yet. Be the first to share your thoughts.